Veterinary Neurodegenerative Disease Diagnostics Market to Reach USD 805.79 Million by 2034 | CAGR of 8.49% Forecasted

Veterinary Neurodegenerative Disease Diagnostics Market

Polaris Market Research analyzes the veterinary neurodegenerative disease diagnostics market, predicting robust growth in the coming years. The market was valued at USD 357.21 million in 2024. Registering a CAGR of 8.49% during 2025-2034, the market is projected to grow to USD 805.79 million by 2034.

Market Overview

Veterinary neurodegenerative disease diagnostics refer to the processes and methods used to identify and assess progressive nervous system disorders in animals. These diseases, such as canine cognitive dysfunction, equine degenerative myeloencephalopathy, and various inherited neuropathies, result in the gradual loss of nerve function. They lead to symptoms like behavioral changes, coordination problems, muscle wasting, and seizures. Diagnosis in veterinary medicine is complex and often requires a combination of clinical examination, neurological assessment, imaging techniques like MRI or CT scans, cerebrospinal fluid (CSF) analysis, and advanced laboratory tests. In some cases, post-mortem examination is used to confirm the diagnosis.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/veterinary-neurodegenerative-disease-diagnostics-market/request-for-sample

Market Growth Drivers

Increasing Disposable Income Worldwide: The rising disposable income across the globe has encouraged pet owners to prioritize their pets' well-being and seek early and specialized treatments. Increased disposable income has also fueled the growth of premium veterinary services. In addition, growing spending power strengthens the pet industry, increasing the accessibility of costly neurodegenerative diagnostics. Therefore, as the global disposable income grows, the veterinary neurodegenerative disease diagnostics market demand continues to rise.

Technological Advancements in Veterinary Neurology: Technological advancements are fueling the demand for neurodegenerative disease diagnostics by improving the speed and accuracy of detection. Advanced imaging techniques, such as high-resolution MRI and CT scanners, are now enabling veterinarians to identify brain abnormalities with greater clarity, encouraging more pet owners to adopt diagnostic testing.

Market Key Players

The veterinary neurodegenerative disease diagnostics market is characterized by intense competition. The top market participants are leveraging product portfolio expansion and strategic developments to garner a large market share. A few of the key market players are:

• ACUVET BIOTECH
• Antech Diagnostics, Inc.
• Avacta Animal Health Limited
• IDEXX Laboratories, Inc.
• Life Diagnostics
• Merck & Co., Inc.
• Mercodia AB
• MI: RNA Diagnostics Ltd.
• Virbac
• Zoetis

Inquire more about this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/veterinary-neurodegenerative-disease-diagnostics-market/inquire-before-buying

Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights

o In terms of product, the consumables, reagents & kits segment accounted for a major share in 2024 due to their essential role in early detection and accurate diagnosis of neurological disorders in animals.
o Based on test, the imaging segment dominated the market share in 2024 due to its critical role in identifying abnormalities in the brain and spinal cord of animals.
o In terms of animal type, the companion segment held the largest share in 2024, owing to the rising prevalence of neurological disorders in aging pets, particularly dogs and cats.
o The North America veterinary neurodegenerative disease diagnostics market accounted for the largest share in 2024 due to the rising prevalence of neurodegenerative disorders in pets, particularly in dog and cat populations.
o The market in Europe is projected to grow at a robust pace in the coming years, owing to the increasing geriatric pet population and growing awareness of neurological disorders.
o The market in Asia Pacific is projected to hold a substantial share in 2034 due to rising pet adoption, increasing disposable income, and improving veterinary healthcare infrastructure.

Market Segmentation

The market is primarily segmented on the basis of product, test, animal type, indication, and end use.

Based on product, the consumables, reagents & kits segment led the global market in 2024. The market dominance of the segment is primarily fueled by its essential role in early detection and accurate diagnosis of neurological disorders in animals. Diagnostic laboratories and veterinarians are increasingly relying on advanced biomarker-based kits to identify conditions such as equine neuroaxonal dystrophy and canine cognitive dysfunction.

By test, the biomarker diagnostic tests segment is anticipated to register robust growth in the coming years. This is largely due to the rising emphasis on early and molecular-level diagnosis. Research advancements in veterinary neuroscience are resulting in the identification of specific veterinary biomarkers in blood and other biological samples, enabling predictive and accurate assessments.

Explore The Complete Report:
https://www.polarismarketresearch.com/industry-analysis/veterinary-neurodegenerative-disease-diagnostics-market

Regional Outlook:

By Regional Outlook (Revenue, USD Million, 2020-2034)
• North America
o US
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Netherlands
o Russia
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Malaysia
o South Korea
o Indonesia
o Australia
o Vietnam
o Rest of Asia Pacific
• Middle East & Africa
o Saudi Arabia
o UAE
o Israel
o South Africa
o Rest of Middle East & Africa
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America

More Trending Reports by Polaris Market Research:

Latin America Fabry Disease Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/latin-america-fabry-disease-treatment-market

MENA Fabry Disease Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/middle-east-north-africa-mena-fabry-disease-treatment-market

LATAM Gaucher Disease Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/latin-america-gaucher-disease-treatment-market

Digital Health For Obesity Market:
https://www.polarismarketresearch.com/industry-analysis/digital-health-for-obesity-market

Chatbot-Based Mental Health Apps Market:
https://www.polarismarketresearch.com/industry-analysis/chatbot-based-mental-health-apps-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.